Negative inotropic effect of low-dose ethanol in mouse ventricular myocytes is mediated by activation of endothelial nitric oxide synthase

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 3, 2005, Pages 343-347

  Zhang, Shengjun ^a   Grover, Gary J ^a   Stokes, Henry ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cardiac myocyte function; Endothelial nitric oxide synthase; Ethanol; Mice; Nitric oxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ALCOHOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE; INOTROPISM; KNOCKOUT MOUSE; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; ETHANOL; GUANYLATE CYCLASE; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXADIAZOLES; QUINOXALINES;

EID: 24344441958     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000175436.49165.8b     Document Type: Article

References (26)

1. Liang Q, Carlson EC, Borgerding AJ. et al. A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther. 1999;291:766-772.
2. Zhang X, Li S-Y, Brown RA, et al. Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress. Alcohol. 2004;32:175-186.
3. Figueredo VM. The effect of alcohol in the heart: detrimental or beneficial? Postgrad Med. 1997;101:167-176.
4. Guppy LJ, Littleton JM. Damaging effects of the calcium paradox are reduced in isolated hearts from ethanol-dependent rats: paradoxic effects of dihydropyridine drugs. J Cardiovasc Pharmacol. 1999;34:765-771.
5. Gaziano JM, Gaziano TA, Glynn TJ, et al. Light to moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000;35:96-105.
6. Miyame M, Diamond I, Weiner MW, et al. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol. 1998;275:H50-H56.
7. Zhou HZ, Karliner JS, Gary MO. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and AKt. Am J Physiol. 2002;283:H165-H174.
8. Pagel PS, Toller WG, Gross ER, et al. ATP-sensitive potassium channels mediate the beneficial effects of chronic ethanol ingestion. Am J Physiol Heart Circ Physiol. 2000;279:H2574-H2579.
9. Nicholas JM, Antunez E, Thomas AP, et al. Ethanol acutely decreases calcium transients in cultured human myotubes. Alcohol Clin Exp Res. 1998;22:1086-1092.
10. Shi J, Larson DF, Yang B, et al. Differential effects of acute ethanol treatment on cardiac contractile function in young adult and senescent mice. Alcohol. 2001;24:197-204.
11. Lazar MJ, Patel K, Scholz PM, et al. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase. J Cardiovasc Pharmacol. 2001;38:512-519.
12. Weiss HR, Haim T, Zhang Q, et al. Ethanol reduces cardiac myocyte function through activation of the nitric oxide-cyclic GMP pathway. Pharmacology. 2003;67:59-66.
13. Zhang X, Klein AL, Alberle NS, et al. Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. J Mol Cell Cardiol. 2003;35:645-654.
14. Baraona E, Shoichet L, Navder K, et al. Mediation by nitric oxide of the stimulatory effects of ethanol on blood flow. Life Sci. 2002;70:2987-2995.
15. Esberg LB, Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia. 2003;46:1419-1427.
16. Su J, Zhang S, Tse J, et al. Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice. Am J Physiol. 2003;285:H2111-H2117.
17. Schoppet M, Maisch B. Alcohol and the heart. Herz. 2001;26:345-352.
18. Mantle D, Preedy VR. Free radicals as mediators of alcohol toxicity. Adverse Drug React Toxicol Rev. 1999;18:235-252.
19. Miyame M, Rodriguez MM, Camacho SA, et al. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci USA. 1997;95:8262-8267.
20. Friedman HS. Cardiovascular effects of alcohol. Recent Dev Alcohol. 1998;14:135-166.
21. Guiraud A, de Lorgeril M, Boucher F, et al. Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J Mol Cell Cardiol. 2004;36:561-566.
22. Cui J, Tosaki A, Bertelli AA, et al. Cardioprotection with white wine. Drugs Exp Clin Res. 2002;28:1-10.
23. Grover GJ, Atwal KS. Pharmacological profile of the mitochondrial- selective ATP-sensitive potassium channel opener BMS-191095 for treatment of acute myocardial ischemia. Cardiovasc Drug Rev. 2002;20: 121-136.
24. Grover GJ, Garlid KD. ATP-sensitive potassium channels: A review of their pharmacology in myocardial ischemia. J Mol Cell Cardiol. 2000;32: 677-695.
25. Layland J, Li JM, Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol. 2002;540:457-467.
26. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol. 2003;35:719-729.